BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27320333)

  • 1. Retinoid X Receptor Selective Agonists and their Synthetic Methods.
    Wagner CE; Jurutka PW; Marshall PA; Heck MC
    Curr Top Med Chem; 2017; 17(6):742-767. PubMed ID: 27320333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of RXR function through ligand design.
    Pérez E; Bourguet W; Gronemeyer H; de Lera AR
    Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in drug design with RXR modulators.
    Vaz B; de Lera ÁR
    Expert Opin Drug Discov; 2012 Nov; 7(11):1003-16. PubMed ID: 22954251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural and synthetic retinoid X receptor ligands and their role in selected nuclear receptor action.
    Brtko J; Dvorak Z
    Biochimie; 2020 Dec; 179():157-168. PubMed ID: 33011201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A naturally occurring rexinoid, honokiol, can serve as a regulator of various retinoid x receptor heterodimers.
    Kotani H; Tanabe H; Mizukami H; Amagaya S; Inoue M
    Biol Pharm Bull; 2012; 35(1):1-9. PubMed ID: 22223330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research resource: transcriptome profiling of genes regulated by RXR and its permissive and nonpermissive partners in differentiating monocyte-derived dendritic cells.
    Széles L; Póliska S; Nagy G; Szatmari I; Szanto A; Pap A; Lindstedt M; Santegoets SJ; Rühl R; Dezsö B; Nagy L
    Mol Endocrinol; 2010 Nov; 24(11):2218-31. PubMed ID: 20861222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural and Structure-based RXR Ligand Scaffolds and Their Functions.
    Dominguez M; Alvarez S; de Lera AR
    Curr Top Med Chem; 2017; 17(6):631-662. PubMed ID: 27320335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoid X receptor agonists modulate Foxp3⁺ regulatory T cell and Th17 cell differentiation with differential dependence on retinoic acid receptor activation.
    Takeuchi H; Yokota-Nakatsuma A; Ohoka Y; Kagechika H; Kato C; Song SY; Iwata M
    J Immunol; 2013 Oct; 191(7):3725-33. PubMed ID: 23980207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
    Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R
    Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists.
    Mukherjee R; Davies PJ; Crombie DL; Bischoff ED; Cesario RM; Jow L; Hamann LG; Boehm MF; Mondon CE; Nadzan AM; Paterniti JR; Heyman RA
    Nature; 1997 Mar; 386(6623):407-10. PubMed ID: 9121558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors.
    Seol W; Choi HS; Moore DD
    Mol Endocrinol; 1995 Jan; 9(1):72-85. PubMed ID: 7760852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure basis of bigelovin as a selective RXR agonist with a distinct binding mode.
    Zhang H; Li L; Chen L; Hu L; Jiang H; Shen X
    J Mol Biol; 2011 Mar; 407(1):13-20. PubMed ID: 21262235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand Design for Modulation of RXR Functions.
    Martínez C; Souto JA; de Lera AR
    Methods Mol Biol; 2019; 2019():51-72. PubMed ID: 31359388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods to Generate an Array of Novel Rexinoids by SAR on a Potent Retinoid X Receptor Agonist: A Case Study with NEt-TMN.
    Wagner CE; Jurutka PW
    Methods Mol Biol; 2019; 2019():109-121. PubMed ID: 31359392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterodimerization among thyroid hormone receptor, retinoic acid receptor, retinoid X receptor, chicken ovalbumin upstream promoter transcription factor, and an endogenous liver protein.
    Berrodin TJ; Marks MS; Ozato K; Linney E; Lazar MA
    Mol Endocrinol; 1992 Sep; 6(9):1468-78. PubMed ID: 1331778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
    Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retinoids: mechanisms of action].
    Berbis P
    Ann Dermatol Venereol; 2010 Nov; 137 Suppl 3():S97-103. PubMed ID: 21185985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast.
    Kephart DD; Walfish PG; DeLuca H; Butt TR
    Mol Endocrinol; 1996 Apr; 10(4):408-19. PubMed ID: 8721985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor α in mouse liver reveals extensive sharing of binding sites.
    Boergesen M; Pedersen TÅ; Gross B; van Heeringen SJ; Hagenbeek D; Bindesbøll C; Caron S; Lalloyer F; Steffensen KR; Nebb HI; Gustafsson JÅ; Stunnenberg HG; Staels B; Mandrup S
    Mol Cell Biol; 2012 Feb; 32(4):852-67. PubMed ID: 22158963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LXR, a nuclear receptor that defines a distinct retinoid response pathway.
    Willy PJ; Umesono K; Ong ES; Evans RM; Heyman RA; Mangelsdorf DJ
    Genes Dev; 1995 May; 9(9):1033-45. PubMed ID: 7744246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.